Esomeprazole and omeprazole may well boost the serum concentrations of benzodiazepines (through CYP2C19 inhibition) bringing about enhanced adverse effects for instance drowsiness, although the scientific relevance is very low for most sufferers – monitor the patient for adverse effects (e.If individual cannot resume their normal oral medication